A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
ROBERTSON, Michael J, KIRKWOOD, John M, LOGAN, Theodore F, KOCH, Kevin M, KATHMAN, Steven, KIRBY, Lyndon C, BELL, William N, THURMOND, Linda M, WEISENBACH, Jill, DAR, Mohammed M
Published in Clinical cancer research (01.06.2008)
Published in Clinical cancer research (01.06.2008)
Get full text
Journal Article
Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
ROBERTSON, Michael J, MIER, James W, JEWELL, Roxanne C, BELL, William N, THURMOND, Linda M, WEISENBACH, Jill, ROBERTS, Suzanne, DAR, Mohammed M, LOGAN, Theodore, ATKINS, Michael, KOON, Henry, KOCH, Kevin M, KATHMAN, Steven, PANDITE, Lini N, OEI, Coreen, KIRBY, Lyndon C
Published in Clinical cancer research (15.07.2006)
Published in Clinical cancer research (15.07.2006)
Get full text
Journal Article
P62SQSTM1 Affects Interacting Substrates MDM2, MDMX and Casein Kinase 1alpha to Yield Protection of Beta-Catenin Along with p53 Silencing for Refractory AML
Layer, Justin, Rangaraju, Sravanti, Pasupuleti, Santhosh, Cripe, Larry D., Sayar, Hamid, Sargent, Katie J, Weisenbach, Jill, Salman, Huda S., Roodman, G. David, Mayo, Linsey, Kapur, Reuben, Dave', Utpal P, Boswell, H. Scott
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Final Results of Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Poor-Risk Cytogenetics
Saliba, Antoine N, Boswell, H. Scott, Cripe, Larry D, Abu Zaid, Mohammad Issam, Weisenbach, Jill, Sayar, Hamid
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Phase I study of recombinant human interleukin-18 (IL-18) in combination with ofatumumab after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoma
Robertson, Michael J., Ni, Lijun, Weisenbach, Jill, Pelloso, David, Prasad, Nagendra K.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma
Robertson, Michael J, Stamatkin, Christopher W, Pelloso, David, Weisenbach, Jill, Prasad, Nagendra K, Safa, Ahmad R
Published in Journal of immunotherapy (1997) (01.04.2018)
Published in Journal of immunotherapy (1997) (01.04.2018)
Get more information
Journal Article
Phase I Study of Recombinant Human Interleukin-18 (IL-18) in Combination with Ofatumumab after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Lymphoma
Robertson, Michael J., Ni, Lijun, Weisenbach, Jill, Pelloso, David, Prasad, Nagendra K.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Monosomy 5, 7, or Complex Cytogenetics
Abu Zaid, Mohammad, Boswell, H. Scott, Cripe, Larry D., Liu, Yan, Weisenbach, Jill, Sayar, Hamid
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma
Robertson, Michael J, Kline, Justin, Struemper, Herbert, Koch, Kevin M, Bauman, John W, Gardner, Olivia S, Murray, Sharon C, Germaschewski, Fiona, Weisenbach, Jill, Jonak, Zdenka, Toso, John F
Published in Journal of immunotherapy (1997) (01.07.2013)
Published in Journal of immunotherapy (1997) (01.07.2013)
Get more information
Journal Article
Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AML
Sayar, Hamid, Liu, Yan, Gao, Rui, Zaid, Mohammad Abu, Cripe, Larry D, Weisenbach, Jill, Sargent, Katie J, Nassiri, Mehdi, Li, Lang, Konig, Heiko, Suvannasankha, Attaya, Pan, Feng, Shanmugam, Rajasubramaniam, Goswami, Chirayu, Kapur, Reuben, Xu, Mingjiang, Boswell, H Scott
Published in Oncotarget (19.01.2018)
Published in Oncotarget (19.01.2018)
Get full text
Journal Article
Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis
Ganjoo, Kristen N., An, Caroline S., Robertson, Michael J., Gordon, Leo I., Sen, Joy A., Weisenbach, Jill, Li, Shuli, Weller, Edie A., Orazi, Attilio, Horning, Sandra J.
Published in Leukemia & lymphoma (01.06.2006)
Published in Leukemia & lymphoma (01.06.2006)
Get full text
Journal Article
Phase I Trial Evaluating the Safety and Biological Activity of Iboctadekin (rhIL-18) in Combination with Rituximab in Patients with CD20+ B Cell Non-Hodgkin's Lymphoma
Robertson, Michael J., Bauman, John, Gardner, Olivia, Jonak, Zdenka, Struemper, Herbert, Germaschewski, Fiona, Koch, Kevin M., Murray, Sharon, Weisenbach, Jill, Toso, John
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Cyclic Administration of Combination of Sorafenib and Vorinostat In Poor-Risk AML: A Pharmacodynamically-Oriented Extended Phase I Trial
Sayar, Hamid, Cripe, Larry, Cangany, Mary, Weisenbach, Jill, Sargent, Katie J., Goswami, Chirayu, Li, Lang, Wilson-Weekes, Annique, Shanmugam, Rajasubramaniam, Boswell, H. Scott
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article